Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Titers”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Not applicableUnknownNCT04387929
What this trial is testing

Detection of Anti-COVID-19 Antibody Levels in an Hospital Population

Who this might be right for
COVID-19
Istituto Clinico Humanitas 6,000
Testing effectiveness (Phase 2)Study completedNCT00478465
What this trial is testing

Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

Who this might be right for
Chronic Fatigue Syndrome
Stanford University 30
Not applicableStudy completedNCT00542776
What this trial is testing

Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

Who this might be right for
Inflammatory Bowel Disease (IBD)Immunosuppressed or Non-ImmunosuppressedInfluenza Vaccine+2 more
Boston Children's Hospital 146
Large-scale testing (Phase 3)Study completedNCT01022749
What this trial is testing

Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

Who this might be right for
Inflammatory Bowel Disease (IBD)
Assistance Publique - Hôpitaux de Paris 228
Not applicableUnknownNCT01046227
What this trial is testing

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

Who this might be right for
Serology AnalysisNovel H1N1 Influenza VaccinationPediatric Haemato-oncology Patients
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06747312
What this trial is testing

Effect of Belimumab on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Not applicableStudy completedNCT00288990
What this trial is testing

A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biogen 300
Early research (Phase 1)Study completedNCT03388645
What this trial is testing

Challenge Infection of Healthy Adult Volunteers With RSV A2

Who this might be right for
Upper Respiratory Tract Infections
National Institute of Allergy and Infectious Diseases (NIAID) 19
Testing effectiveness (Phase 2)Study completedNCT05625477
What this trial is testing

Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers

Who this might be right for
Tetanus
Zhuhai Trinomab Pharmaceutical Co., Ltd. 240
Not applicableUnknownNCT05087277
What this trial is testing

Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain

Who this might be right for
COVID-19
Centers for Disease Control and Prevention, China 150
Post-approval studies (Phase 4)Study completedNCT02039440
What this trial is testing

6-year Antibody Check After Third Vaccination Against Japanese Encephalitis

Who this might be right for
Post Other Specified Vaccination Encephalitis
Medical University of Vienna 67
Post-approval studies (Phase 4)Study completedNCT06252051
What this trial is testing

Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)

Who this might be right for
InfluenzaVaccine ReactionDiabetes Mellitus+1 more
Universitas Padjadjaran 76
Large-scale testing (Phase 3)UnknownNCT04182737
What this trial is testing

Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock.

Who this might be right for
Shock, SepticSepsisHypoglobulinemia
Massimo Girardis 356
Large-scale testing (Phase 3)Study completedNCT05549908
What this trial is testing

Vaccine Prevention of Rabies Adopts 4-shot Immunization Method

Who this might be right for
Rabies HumanAntibody Titer
Changchun Zhuoyi Biological Co., Ltd 1,800
Early research (Phase 1)Study completedNCT00119873
What this trial is testing

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableUnknownNCT01742728
What this trial is testing

Nagasaki and Tokushima

Who this might be right for
Periodontitis
University of Tokushima 2,000
Not applicableStudy completedNCT05104359
What this trial is testing

COVID-19 Quantitative Antibody Titers & Booster Vaccinations

Who this might be right for
COVID-19COVID-19 VaccinesImmunogenicity, Vaccine
Epividian 825
Testing effectiveness (Phase 2)Study completedNCT06315530
What this trial is testing

Effect of Telitacicept on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Not applicableStudy completedNCT02006784
What this trial is testing

Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Vanderbilt University 17
Next Page